Ftse Mib
36.143,83
-0,34%
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
101.465,02
-0,55%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Purple Biotech Ltd (PPBT) Purple Biotech Ltd (PPBT) Notizie

Purple Biotech Ltd

PPBT
3,54
-0,18 (-4,84%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/1/202523:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202522:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202413:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202413:13GLOBEPurple Biotech Announces Closing of $2.8 Million Registered..
04/12/202417:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202415:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/12/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/12/202414:23GLOBEPurple Biotech Announces $2.8 Million Registered Direct..
02/12/202413:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/12/202413:00GLOBEPurple Biotech Reports Positive Final Results from..
15/11/202413:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202413:00GLOBEPurple Biotech Reports Third Quarter 2024 Financial Results
04/11/202413:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202413:50GLOBEPurple Biotech Identifies Potential New Serum Biomarker for..
25/10/202413:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202413:20GLOBEPurple Biotech Presents New Data for its Novel Tri-Specific..
10/10/202413:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202413:30GLOBEPurple Biotech to Present Data for its Tri-Specific Antibody..
09/10/202413:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202412:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202412:30GLOBEPurple Biotech Reports Additional Positive Interim Data from..
11/9/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/9/202413:00GLOBEPurple Biotech to Present Data for its Lead Oncology Drug..
30/8/202413:00GLOBEPurple Biotech to Participate at H.C. Wainwright 26th Annual..
19/8/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202414:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202414:12GLOBEPurple Biotech Reports Second Quarter 2024 Financial Results..
08/8/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/8/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
25/7/202413:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202413:35GLOBEPurple Biotech Receives Extension to Regain Compliance with..
22/7/202423:00EDGAR2Form F-1 - Registration statement for certain foreign..
19/7/202414:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202413:30GLOBEPurple Biotech to Host Virtual KOL Event to Discuss Positive..
02/7/202422:00GLOBEPurple Biotech Announces Closing of Exercise of Warrants for..
01/7/202415:00GLOBEPurple Biotech Announces Exercise of Warrants for $2 Million..
27/6/202413:45GLOBEPurple Biotech Reports Additional Positive Interim Results..
20/6/202415:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/6/202412:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/6/202414:00GLOBEPurple Biotech Announces Positive Late-Breaking Interim..
21/5/202413:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202413:30GLOBEPurple Biotech Reports First Quarter 2024 Financial Results
25/4/202413:00GLOBEPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer..
28/3/202412:00GLOBEPurple Biotech to Present New Data On its Oncology Drug..
14/3/202412:30GLOBEPurple Biotech Reports Preclinical Proof of Concept for its..
06/3/202422:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 3,74 Min: 3,52 Max: 3,90
Chiusura: 3,72

La tua Cronologia

NASDAQ
PPBT
Purple Biotech
BIT
BENE
WisdomTree Energy Enhanced
ASX
CND
Condor Energy
BIT
EVAAXA
Askoll EVA
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network